Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Interest Coverage Ratio (2016 - 2024)

Sunshine Biopharma's Interest Coverage Ratio history spans 11 years, with the latest figure at 238.92 for Q4 2024.

  • For Q4 2024, Interest Coverage Ratio fell 505.93% year-over-year to 238.92; the TTM value through Sep 2025 reached 759.14, down 1129.11%, while the annual FY2024 figure was 662.43, 1800.74% down from the prior year.
  • Interest Coverage Ratio reached 238.92 in Q4 2024 per SBFM's latest filing, up from 5176.64 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 1.99 in Q2 2021 to a low of 858990.0 in Q3 2022.
  • Average Interest Coverage Ratio over 5 years is 48104.26, with a median of 26.56 recorded in 2024.
  • Peak YoY movement for Interest Coverage Ratio: crashed 8109137.82% in 2022, then soared 100.0% in 2023.
  • A 5-year view of Interest Coverage Ratio shows it stood at 3.26 in 2020, then crashed by 134.44% to 7.63 in 2021, then crashed by 11429.02% to 880.12 in 2022, then soared by 95.52% to 39.43 in 2023, then crashed by 505.93% to 238.92 in 2024.
  • Per Business Quant, the three most recent readings for SBFM's Interest Coverage Ratio are 238.92 (Q4 2024), 5176.64 (Q2 2024), and 27.46 (Q1 2024).